Cardioprotection of red wine: Role of polyphenolic antioxidants

Drugs under Experimental and Clinical Research

Volumn 25, Issue 2-3, 1999, Pages 115-120

  Das, Dipak K ^a   Sato, M ^a   Ray, P S ^a   Maulik, G ^b   Engelman, R M ^c   Bertelli, A A E ^d   Bertelli, A ^d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATECHIN; EPICATECHIN; FREE RADICAL; POLYPHENOL; PROANTHOCYANIDIN; RESVERATROL;

CONFERENCE PAPER; GRAPE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PLANT SEED; REPERFUSION INJURY; WINE;

ANTIOXIDANTS; CORONARY DISEASE; FLAVONOIDS; HUMANS; PHENOLS; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; POLYMERS; REPERFUSION INJURY; STILBENES; WINE;

EID: 0033034560     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Rimm E.B., Giovannucci E.L., Willett W.C., et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet, 338, 46, 1991.
2. St. Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1, 1017, 1979.
3. Gaziano J.M., Buring J.E., Breslow J.L., et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subtractions and decreased risk of myocardial infarction. N. Engl. J. Med., 329, 1829, 34, 1993.
4. Frankel E.N., Kanner J., German J.B. Inhibition of human low-density lipoprotein by phenolic substances in red wine. Lancet, 341, 454, 1993.
5. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of tissue-type plasminogen activator J.A.M.A., 272, 929, 1994.
6. Mikhailidis D.P., Jeremy J.Y., Bar Tadas M.A., Green N., Dandona P. Effect of ethanol on vascular prostacychn synthesis, platelet aggregation and platelet thromboxane release. Br. Med. J., 287, 1495, 1993.
7. Demrow H., Slane P., Folts J. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation, 91, 1182, 1995.
8. Saija A., Marzullo D., Scalese M., Bonina F., Laiza M., Castelli F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Rad. Biol. Med., 19, 481, 1995.
9. Fauconneau B., Barrier L., Waffo-tegno P., Decendit A., Hugnet F., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci., 61, 2103, 1997.
10. Hertog M.G.L., Feskens E.J.M., Kromhout D. Antioxidantflavonols and coronary heart disease risk. Lancet, 349, 699, 1997.
11. Renaud S., De Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet, 342, 1007, 1993.
12. Das D.K., Maulik N. Protection against free radical injury in the heart and cardiac performance. In: Sen C.K., Packer L., Hanninen O. (Eds.). "Exercise and Oxygen Toxicity." Elsevier Science, Amsterdam, 1995, pp. 359-388.
13. Arroyo C.M., Kramer J.H., Dickens B.F., Weglicki W.B. Identification off free radicals in myocardial ischemia/reperfusion by spin trapping with mtrone DMPO. FEBS Lett., 221, 101, 1987.
14. Das D.K., Maulik N. Protection against free radical injury in the heart and cardiac performance. In: Sen C.K., Packer L., Hanninen O. (Eds.). "Exercise and Oxygen Toxicity". Elsevier Science, Amsterdam, 1995, pp. 359-388.
15. Gey K.F., Nska P., Jordan P., Moser U.K., Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr., 53, 3265, 1991.
16. Tosaki A., Bagchi D., Hellegouarch P.T., Cordis G.A., Das, D.K. Comparisons of ESR and HPLC methods for the detection of hyroxyl radicals in ischemic/reperfused hearts. A relationship between the genesis of oxygen-free radicals and reperfusion-induced arrythmias. Biochem. Pharmacol., 45, 961, 1993.
17. Cordis G.A., Maulik N., Das D.K. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J. Mol. Cell Cardiol., 27, 1645, 1995.
18. Cordis G.A., Maulik G., Bagchi D., Riedel W., Das D.K. Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. J. Mol. Cell Cardiol., 30, 1939, 1998.
19. Das D.K., Maulik N. Evaluation of antioxidant effectiveness in ischemia reperfusion tissue injury methods. Methods Enzymol., 233, 601, 1994.
20. Das D.K., Engelman R.K., Rousou J.A., Breyer R.H., Otani H., Lemeshow S. Pathophysiology of superoxide radical as potential mediator of ischemic and reperfusion injury in pig heart. Basic Res. Cardiol., 81, 155, 1986.
21. Engelman D., Watanabe M., Engelman R.M., et al. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc. Res., 29, 133, 1995.
22. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Res., 59, 527, 1979.
23. Frei B., Stocker R., Ames B.N. Antioxidant defences and lipidperoxidation in human bloodplasma. Proc. Natl. Acad. Sci., 85, 9748, 1988.
24. Stocker R., Peterhans E. Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin. Biochim. Biophys. Acta, 1002, 238, 1989.
25. Makrigiorgos G.M., Kassis A., Mahmood A., Bump E., Sawides P. Novel fluorescein-based flow cytometric method for detection of lipidperoxidation. Free Rad. Biol. Med., 22, 93, 1997.